Daily Derm Times: June 18, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Journal Digest: June 18, 2025

This review of the latest dermatologic studies includes insights into differences in vitamin D levels in rosacea versus healthy individuals, psychosocial determinants and atopic dermatitis outcomes, and more.

Inside IL-17 Inhibitors Advancing Psoriasis Care

Explore the latest insights on IL-17 inhibitors for psoriasis, highlighting their mechanisms, real-world benefits, and future treatment strategies.

German Study Explores the Emotional Impact of Work-Related CHE

A study reveals the significant emotional burden of work-related chronic hand eczema, highlighting the need for tailored psychological support for affected patients.

Shifting the Paradigm in Infant Atopic Dermatitis Treatment with Roflumilast

Pediatric dermatologist Mercedes E. Gonzalez, MD, discusses roflumilast's promise as a safe, non-steroidal treatment for atopic dermatitis in infants.

Inclusive Language in Dermatology May Improve LGBTQ+ Patient Outcomes and Data Accuracy, Study Finds

LGBTQ+-inclusive language in dermatology enhances patient care, addresses health barriers, and improves outcomes for transgender individuals facing acne challenges.

Both Upadacitinib and Abrocitinib Demonstrate Real-World Efficacy in AD Patients After 1 Year

A real-world study shows the effectiveness of upadacitinib and abrocitinib for moderate-to-severe atopic dermatitis after 52 weeks of treatment.